Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ — Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides in addressing chronic insomnia among U.S. veterans. The company’s FDA-cleared, drug-free insomnia treatment device, Modius Sleep, is now available to veterans through the U.S. Department of Veterans Affairs (VA) program.
